PMGC Holdings (ELAB) Goodwill (2025 - 2026)
PMGC Holdings' (ELAB) quarterly Goodwill came in at $3.0 million in Q2 2026, up 63.4% quarter-over-quarter from $1.9 million in Q1 2026.
Analysis
PMGC Holdings (ELAB) Goodwill (2025 - 2026) Analysis & Trends
PMGC Holdings has disclosed Goodwill across 2 years of filings, most recently posting $3.0 million for Q2 2026.
- In Q2 2026, Goodwill changed N/A year-over-year to $3.0 million; the TTM figure through Jun 2026 stood at $3.0 million (changed N/A YoY), while the FY2025 annual figure was $977774.0, changed N/A from the prior year.
- Goodwill came in at $3.0 million for Q2 2026 at PMGC Holdings, up from $1.9 million in the prior quarter.
- In the past five years, Goodwill ranged from a high of $3.0 million in Q2 2026 to a low of $959535.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 207.11 Bn | 193.12 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 178.91 Bn | 175.73 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 131.35 Bn | 123.50 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.84 Bn | 73.85 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.06 Bn | 55.87 Bn | 1.37 Bn |
| 6 | Moderna | 53.08 Bn | 47.94 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.32 Bn | 30.01 Bn | 992.69 Mn |
| 8 | Biogen | 31.70 Bn | 30.41 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.48 Bn | 29.48 Bn | 1.16 Mn |
| 10 | PMGC Holdings | 2.23 Mn | -16.56 Mn | 385,691.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.04 Mn |
| Mar 31, 2026 | 1.86 Mn |
| Dec 31, 2025 | 977,774.00 |
| Sep 30, 2025 | 959,535.00 |